Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Aims Rheumatoid arthritis is a chronic inflammatory condition that affects approximately 1%
of the world's population. There are a wide number of guidelines and recommendations …

Sixty percent of patients with arthritis have used complementary and alternative medicine
(CAM) therapies at least once. The two most common types of arthritis include rheumatoid …

Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …

Objective To compare the efficacy, safety, and tolerability of 4 doses of oral tofacitinib (CP‐
690,550) with placebo in Japanese patients with active rheumatoid arthritis (RA) receiving …

Objective. An all-patient postmarketing surveillance program was conducted to evaluate the
safety and effectiveness of tocilizumab (TCZ) for rheumatoid arthritis (RA) in the real-world …

Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis. Here, tofacitinib safety and efficacy data from a long-term extension study in …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Objective An interim analysis of an all-patient postmarketing surveillance programme in
Japan to investigate the safety of tocilizumab for the treatment of rheumatoid arthritis (RA) in …

Objectives. To evaluate oral tofacitinib versus placebo for treatment of active rheumatoid
arthritis in Japanese patients with inadequate response to disease-modifying antirheumatic …